Thierry Gil

9.2k citations
81 papers · 6.6k · 6 hit papers · h-index 27

Impact in

Papers in

    • Prostate Cancer Treatment and Research 18
    • Sarcoma Diagnosis and Treatment 10
    • Renal cell carcinoma treatment 6
    • Cancer Treatment and Pharmacology 10
    • Cancer Immunotherapy and Biomarkers 5

Thierry Gil

80 papers receiving 6.4k citations

Thierry Gil's Hit Papers

Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial 2020 · 400 citations
4000+9+19Years since publication4008001.2k

Peers

Thierry Gil
Comparison fields: 5 of 99
  • Pulmonary and Respiratory Medicine 3.5k
  • Gastroenterology 582
  • Oncology 1.6k
  • Cancer Research 540
  • Surgery 1.4k
Replace Kanishka Sircar with:
Kanishka Sircar United States
Michael Montemurro Switzerland
David C. Harmon United States
Beatrice M. Seddon United Kingdom
Antonio Lopez Pousa Spain
Do Hoon Lim South Korea
David A. Spooner United Kingdom
Katja Ott Germany
Sandrine I. Marreaud Belgium
Julien Dômont France
Thierry Gil relative to Kanishka Sircar United States Kanishka Sircar's profile →
Citations per field
00.5×1.5×
Kanishka Sircar · 1×
Citations per year

Countries citing papers authored by Thierry Gil

Since Specialization
Citations

This map shows the geographic impact of Thierry Gil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Gil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Gil more than expected).

Fields of papers citing papers by Thierry Gil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Gil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Gil. The network helps show where Thierry Gil may publish in the future.

Co-authors

The 25 scholars most cited alongside Thierry Gil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thierry Gil Line = papers co-authored together Thierry Gil links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
Hit paper breakdown →
19971275
2
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Hit paper breakdown →
20181096
3
Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986
Hit paper breakdown →
2011608
4
Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Hit paper breakdown →
2018598
5
Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Hit paper breakdown →
2018436
6
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial
Hit paper breakdown →
2020400
7 2005293
8 2013252
9 2011150
10 2009103
11 201698
12 201886
13 201584
14 201376
15 202274
16 201062
17 201653
18 201342
19 200841
20 201940

About Thierry Gil

Thierry Gil is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Hematology, Surgery and Radiology, Nuclear Medicine and Imaging, having authored 81 papers that have together received 6.6k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (18 papers), Cancer Treatment and Pharmacology (10 papers), Sarcoma Diagnosis and Treatment (10 papers), Renal cell carcinoma treatment (6 papers), Bladder and Urothelial Cancer Treatments (6 papers), Radiopharmaceutical Chemistry and Applications (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Multiple Myeloma Research and Treatments (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.5k citations), Gastroenterology (582 citations), Oncology (1.6k citations), Cancer Research (540 citations) and Surgery (1.4k citations). Thierry Gil has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include Laurence Collette, Cora Nanette Sternberg, Dionisio González, Padraig Richard Warde, René‐Olivier Mirimanoff, M. Bolla, Marianne Piérart, Jacques Bernier, Abraham Kuten and Guy A Storme. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, British Journal of Cancer, Annals of Nuclear Medicine and Anti-Cancer Drugs.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact